PIM1 and cancer: Although dysregulations of the NEK2, PIM1, and PIM3 kinase signaling axes have been implicated in the pathogenesis of several cancers [10, 11], including those with a neuroendocrine phenotype [12, 13], their role in the pathogenesis of BP-NENs has not been determined.